---
title: "Psych News Alert: Meta-analysis of Chantix's Cardiovascular Risk Completed"
description: The results are in, and they're not as daunting as expected. When the Food and Drug Administration (FDA) first expressed concerns about ...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/stopsmoker_65367250-Jun-24-2025-04-20-19-2767-PM.jpg
---

 12/19/12 12:00 AM

# Meta-analysis of Chantix's Cardiovascular Risk Completed

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html)

| [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/stopsmoker_65367250-Jun-24-2025-04-20-20-0780-PM.jpg?width=133&height=200&name=stopsmoker_65367250-Jun-24-2025-04-20-20-0780-PM.jpg)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/stopsmoker_65367250-Jun-24-2025-04-20-20-0780-PM.jpg) |  |
| --- | --- |

The results are in, and they're not as daunting as expected. When the Food and Drug Administration (FDA) first expressed concerns about possible increased risk of cardiovascular adverse events associated with the smoking-cessation drug Chantix (varenicline) in a Drug Safety Communication (DSC) in June 2011, one of the steps the agency said it would take would be to require Pfizer, the drug’s manufacturer, to conduct a meta-analysis of controlled trials of the drug. The FDA has now presented the results of that meta-analysis, which showed a higher occurrence of major adverse cardiovascular events (a combined outcome of cardiovascular-related death, nonfatal heart attack, and nonfatal stroke) in patients using Chantix compared with those on placebo. These events, however, were uncommon in both the Chantix and placebo groups, and the increased risk was not statistically significant, which means it is uncertain whether the excess risk for the Chantix group was due to the drug or to chance.

The FDA advised health care professionals to weigh the risks of Chantix against its benefits, while noting that smoking is a major risk factor for cardiovascular disease, and Chantix is effective in helping patients quit smoking and abstain from it for as long as one year. “The health benefits of quitting smoking are immediate and substantial,” the agency emphasized in the communication. The Warnings and Precautions section of the Chantix label has been updated to include the results of the meta-analysis.

The DSC is posted at [www.fda.gov/Drugs/DrugSafety/ucm330367.htm](http://www.fda.gov/Drugs/DrugSafety/ucm330367.htm) .

Data have also suggested that varenicline may be an effective treatment for patients with schizophrenia. Read more about that topic in *Psychiatric News* [here](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=179712). And for a study of genetic risk and smoking-cessation treatment, see the *American Journal of Psychiatry* [here](http://ajp.psychiatryonline.org/article.aspx?articleid=1169679). 

   (Image: Goodluz/Shutterstock.com)

[smoking cessation](https://alert.psychnews.org/tag/smoking-cessation), [Chantix](https://alert.psychnews.org/tag/chantix), [cardiovascular risk](https://alert.psychnews.org/tag/cardiovascular-risk)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/shutterstock_178759595-Jun-24-2025-04-31-50-2979-PM.jpg?height=200&name=shutterstock_178759595-Jun-24-2025-04-31-50-2979-PM.jpg) ](https://alert.psychnews.org/2015/03/fda-warns-about-seizures-drinking-while.html)

[psychiatry](https://alert.psychnews.org/tag/psychiatry), [FDA warning](https://alert.psychnews.org/tag/fda-warning), [varenicline](https://alert.psychnews.org/tag/varenicline), [smoking cessation](https://alert.psychnews.org/tag/smoking-cessation), [Chantix](https://alert.psychnews.org/tag/chantix), [adverse events](https://alert.psychnews.org/tag/adverse-events), [Pfizer](https://alert.psychnews.org/tag/pfizer), [FDA](https://alert.psychnews.org/tag/fda)

## [FDA Warns About Seizures, Drinking While Using Chantix](https://alert.psychnews.org/2015/03/fda-warns-about-seizures-drinking-while.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 3/11/15 12:00 AM

The smoking-cessation medication varenicline (Chantix; Pfizer) may cause problems in people who...

[ Read more ](https://alert.psychnews.org/2015/03/fda-warns-about-seizures-drinking-while.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/cocaine_82363048-Jun-24-2025-04-19-18-6414-PM.jpg?height=200&name=cocaine_82363048-Jun-24-2025-04-19-18-6414-PM.jpg) ](https://alert.psychnews.org/2012/01/chantix-may-be-next-treatment-for.html)

[varenicline](https://alert.psychnews.org/tag/varenicline), [Chantix](https://alert.psychnews.org/tag/chantix), [cocaine dependence](https://alert.psychnews.org/tag/cocaine-dependence)

## [Chantix May Be Next Treatment for Cocaine Addiction](https://alert.psychnews.org/2012/01/chantix-may-be-next-treatment-for.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 1/26/12 12:00 AM

[ Read more ](https://alert.psychnews.org/2012/01/chantix-may-be-next-treatment-for.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/chantix_64673722-Jun-24-2025-04-18-51-8941-PM.jpg?height=200&name=chantix_64673722-Jun-24-2025-04-18-51-8941-PM.jpg) ](https://alert.psychnews.org/2013/09/key-ingredient-in-chantix-does-not.html)

[varenicline](https://alert.psychnews.org/tag/varenicline), [smoking cessation](https://alert.psychnews.org/tag/smoking-cessation), [Chantix](https://alert.psychnews.org/tag/chantix)

## [Key Ingredient in Chantix Does Not Appear to Cause Psychiatric Events, Study Finds](https://alert.psychnews.org/2013/09/key-ingredient-in-chantix-does-not.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 9/13/13 12:00 AM

As Pfizer Pharmaceuticals pays out millions of dollars in claims related to depression and suicide...

[ Read more ](https://alert.psychnews.org/2013/09/key-ingredient-in-chantix-does-not.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T16:24:27.690Z",
  "datePublished" : "2012-12-19T05:00:00.000Z",
  "headline" : "Psych News Alert: Meta-analysis of Chantix's Cardiovascular Risk Completed",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/stopsmoker_65367250-Jun-24-2025-04-20-19-2767-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2012/12/meta-analysis-of-chantix-cardiovascular.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```